A Phase 2 Study of the Safety and Efficacy of INCB050465 in Combination with Ruxolitinib in Patients with Myelofibrosis (MF)

被引：1
|
作者：
Daver, Naval [1 ]
Dao, Kim-Hien [2 ]
Assad, Albert [3 ]
Verstovsek, Srdan [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[3] Incyte Corp, Wilmington, DE USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷
关键词：
D O I：
10.1016/j.clml.2017.07.177
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MPN-028
引用
收藏
页码：S351 / S351
页数：1
相关论文
共 50 条
  • [21] Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis
    Gowin, K.
    Kosiorek, H.
    Dueck, A.
    Mascarenhas, J.
    Hoffman, R.
    Reeder, C.
    Camoriano, J.
    Tibes, R.
    Gano, K.
    Palmer, J.
    Mesa, R.
    LEUKEMIA RESEARCH, 2017, 60 : 31 - 35
  • [22] Navitoclax in Combination with Ruxolitinib in Patients with Primary or Secondary Myelofibrosis: A Phase 2 Study
    Harrison, Claire
    Garcia, Jacqueline S.
    Mesa, Ruben
    Somervaille, Tim
    Ritchie, Ellen K.
    Komrokji, Rami S.
    Pemmaraju, Naveen
    Jamieson, Catriona
    Papadantonakis, Nikolaos
    Foran, James M.
    O'Connell, Casey L.
    Verstovsek, Srdan
    Jung, Paul
    Holes, Leanne
    Masud, Abdullah
    Harb, Jason
    Hutti, Jessica E.
    Prchal, Josef T.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S325 - S325
  • [23] Safety and Efficacy of Ruxolitinib in Patients with Low Platelets Enrolled in a Phase 3b Expanded-Access Study in Myelofibrosis (MF)
    Griesshammer, Martin
    Vannucchi, Alessandro M.
    le Coutre, Philipp
    Tavares, Renato S.
    Al-Ali, Haifa Kathrin
    Raanani, Pia
    Gupta, Vikas
    Foltz, Lynda M.
    Giraldo, Pilar
    Bouard, Catherine
    Ronco, Julian Perez
    Ghosh, Jagannath
    Martino, Bruno
    BLOOD, 2014, 124 (21)
  • [24] Safety and efficacy of the combination of sonidegib and ruxolitinib in myelofibrosis: a phase 1b/2 dose-finding study
    Gupta, Vikas
    Wolleschak, Denise
    Hasselbalch, Hans
    Vannucchi, Alessandro Maria
    Koschmieder, Steffen
    Cervantes, Francisco
    Li, Yang
    Dong, Tuochuan
    Wroclawska, Monika
    Bharathy, Savita
    Harrison, Claire
    BLOOD ADVANCES, 2020, 4 (13) : 3063 - 3071
  • [25] Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study
    Francisco Cervantes
    David M. Ross
    Atanas Radinoff
    Francesca Palandri
    Alexandr Myasnikov
    Alessandro M. Vannucchi
    Pierre Zachee
    Heinz Gisslinger
    Norio Komatsu
    Lynda Foltz
    Francesco Mannelli
    Francesco Passamonti
    Geralyn Gilotti
    Islam Sadek
    Ranjan Tiwari
    Evren Zor
    Haifa Kathrin Al-Ali
    Leukemia, 2021, 35 : 3455 - 3465
  • [26] A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis
    Stephen Couban
    Giulia Benevolo
    William Donnellan
    Jennifer Cultrera
    Steffen Koschmieder
    Srdan Verstovsek
    Gregory Hooper
    Christian Hertig
    Maneesh Tandon
    Natalie Dimier
    Vikram Malhi
    Francesco Passamonti
    Journal of Hematology & Oncology, 11
  • [27] A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis
    Couban, Stephen
    Benevolo, Giulia
    Donnellan, William
    Cultrera, Jennifer
    Koschmieder, Steffen
    Verstovsek, Srdan
    Hooper, Gregory
    Hertig, Christian
    Tandon, Maneesh
    Dimier, Natalie
    Malhi, Vikram
    Passamonti, Francesco
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [28] Safety and Efficacy of Combined Ruxolitinib and Thalidomide in Patients with Myelofibrosis: Initial Results of a Phase II Study
    Rampal, Raajit K.
    Verstovsek, Srdan
    Devlin, Sean M.
    Stein, Eytan M.
    Kadia, Tapan M.
    Mauro, Michael J.
    Pemmaraju, Naveen
    Alvarez, Kelsey
    Ard, Nicole
    Goodman, Tawni
    Marek, Kelly
    Bose, Prithviraj
    BLOOD, 2018, 132
  • [29] Safety and Efficacy of Combined Ruxolitinib and Thalidomide in Patients With Myelofibrosis: Initial Results of a Phase II Study
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (01) : 8 - 10
  • [30] Phase 2 study of ruxolitinib in combination with 5-azacitidine in patients with myelofibrosis.
    Masarova, Lucia
    Cortes, Jorge E.
    Pemmaraju, Naveen
    Jabbour, Elias
    Bose, Prithviraj
    Ohanian, Maro
    Zhou, Lingsha
    Pierce, Sherry
    Gergis, Romany
    Borthakur, Gautam
    Estrov, Zeev
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    Daver, Naval Guastad
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345